Microbiology

Napyradiomycin B2 is an antibiotic that primarily targets Gram-positive bacteria and exhibits significant activity against mycobacteria. Its efficacy is limited against Gram-negative bacteria and fungi, making it a valuable compound for research into antimicrobial mechanisms and the development of new antibacterial agents. Napyradiomycin B2 is particularly relevant for studies investigating treatment options for infections caused by mycobacterial pathogens.

Saptomycin E is an antibiotic that exhibits antitumor properties by targeting and inhibiting bacterial protein synthesis. Its unique mechanism of action makes it a valuable tool for research in cancer biology and antibiotic development. This compound is effective in studying cell growth modulation and exploring therapeutic options against resistant bacterial strains.

Halomicin C is an ansamycin antibiotic that demonstrates antibacterial activity against both Gram-positive and Gram-negative bacteria. It serves as a valuable tool in microbiological research and the development of new antimicrobial agents, providing insights into bacterial resistance mechanisms and potential therapeutic applications.

Sannamycin G is an aminoglycoside antibiotic that exerts its activity primarily by inhibiting bacterial protein synthesis. While it demonstrates weak antibacterial activity against select bacterial strains, it serves as a valuable tool for research into antibiotic mechanisms and resistance. Its characterization can aid in the development of novel therapeutic strategies and the exploration of bacterial interactions.

Parvodicin C4 is a glycopeptide antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates significant inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable for research applications focused on antibiotic resistance mechanisms and the development of new antimicrobial therapies.

11-Deoxy-13-dihydrodaunorubicin is an anthracycline antibiotic that primarily targets bacterial and tumor cells. It exhibits significant antibacterial activity against Gram-positive and negative bacteria, alongside notable antitumor properties. This compound is valuable for research applications in the fields of microbiology and oncology, particularly in the study of antibiotic resistance and cancer treatments.

Miyakamide A2 is an antitumor antibiotic known for its insecticidal properties. It effectively inhibits the growth of Artemia salina and demonstrates moderate antixanthomonas activity. Additionally, Miyakamide A2 exhibits cytotoxic effects on P388 cancer cells, with an IC50 value of 12.2 μg/mL, making it applicable in cancer research and potential therapeutic development.

Deoxyfrenolicin is a quinone antibiotic that targets bacterial proliferation. Isolated from the fermentation broth of Streptomyces roseofulvus strain AM-3867, it belongs to the frenolicin class of antibiotics. Deoxyfrenolicin demonstrates significant antibacterial activity in vitro, effectively inhibiting the growth of Mycoplasma gallisepticum. This compound serves as a valuable tool for research applications in microbiology and antibiotic resistance studies.

Porothramycin B is an antibiotic that exhibits activity against Gram-positive and anaerobic bacteria. Its mechanism of action involves inhibiting bacterial protein synthesis, making it a valuable tool for studying bacterial infections. Researchers can utilize Porothramycin B in various microbiological applications, including the investigation of bacterial resistance mechanisms and the development of new therapeutic strategies.

Sakyomicin D is a benzoquinone antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity against Gram-positive bacteria. This compound is utilized in research focused on combating antibiotic resistance and exploring novel antibacterial mechanisms. Its unique structure and mechanism of action make it a valuable tool for studying microbial pathogenesis and the development of new therapeutic agents.

Dapdiamide A is an antibiotic that targets bacterial cell viability, derived from the Pantoea agglomerans CU0119 strain. It demonstrates significant antibacterial activity, making it a valuable compound for anti-infective research applications. This compound may contribute to the development of novel therapeutic strategies against bacterial infections.

Epihygromycin is a glycoside antibiotic primarily targeting bacterial ribosomes. It exhibits modest activity against Gram-positive bacteria, making it valuable for studies on antibiotic resistance and microbial bioassays. Its mechanism of action facilitates investigations into bacterial protein synthesis and the efficacy of antibiotic treatments.

Pyridindolol K2 is an alkaloid antibiotic derived from Streptomyces species K93-0711. It exhibits the ability to inhibit the adhesion of HL-60 cells, making it a valuable tool for studying cell adhesion mechanisms and potential therapeutic applications. This compound is of interest in the development of novel antibacterial agents and in various cancer research applications.

Oxanosine is an antibiotic derived from the Streptomyces MG265-CF34 strain, exhibiting notable anti-tumor properties. This compound functions as a substrate for adenosine deaminase, highlighting its potential utility in various research applications related to microbial activity and cancer treatment. Its unique biochemical interactions make it a valuable reagent for studies in antibiotic development and tumor biology.

5-Hydroxy-4-oxo-L-norvaline is an antifungal antibiotic that inhibits protein biosynthesis in microbial cells. Its mechanism of action makes it a valuable tool in studying fungal growth and resistance. This compound is particularly useful for research applications focused on understanding antifungal mechanisms and the development of new therapeutic strategies against fungal infections.

Fluvirucin B2 is an antibiotic that specifically targets the influenza A virus. It exhibits antiviral activity by inhibiting viral replication, making it a valuable tool in researching antiviral therapeutic strategies. Fluvirucin B2 can be utilized in studies focused on understanding influenza pathogenesis and the development of effective antiviral agents.

Reumycin is a 7-azapteridine antibiotic that functions as an antitumor agent. It exhibits cytotoxic activity against various tumor cell lines, including Airy carcinoma, sarcoma-180, sarcoma-37, and lymphosarcoma. This compound is primarily utilized in cancer research to study its effects on tumor proliferation and cell viability.

Pluracidomycin C2 is a carbapenem antibiotic that targets bacterial cell wall synthesis. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance and microbial pathogenicity. Its unique mechanism of action and broad-spectrum efficacy render it useful for various research applications in microbiology and pharmacology.

Piperic acid is an antibacterial agent that exhibits natural antioxidant properties. It is recognized for its ability to inhibit bacterial growth, making it valuable for applications in food preservation and health-related research. Its utility in investigating antibacterial mechanisms further enhances its relevance in the study of microbial infections and therapeutic development.

Monamycin H2 is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it valuable in microbiological research. This compound is utilized to study antibiotic resistance and the mechanisms of bacterial growth inhibition.

Laidlomycin phenylcarbamate functions as a semisynthetic polyether antibiotic that exhibits notable antiparasitic activity. Its mechanism involves inhibiting protein synthesis, making it valuable for research into antimicrobial resistance and therapies involving parasitic infections. This compound is relevant in the study of antibiotic efficacy and the development of new treatments in infectious disease research.

Paldimycin B is a semi-synthetic antibiotic that exerts its activity primarily against Staphylococcus aureus and coagulase-negative staphylococci. It demonstrates significant antibacterial properties, making it valuable for research focused on bacterial infections and antibiotic resistance mechanisms. This compound serves as a useful tool for studying the efficacy and resistance profiles of various bacterial strains in the context of antimicrobial therapy.

Desacetylcephalothin sodium is a metabolite of the antibiotic Cephalothin, primarily targeting bacterial cell wall synthesis. Although it exhibits relatively weak antimicrobial activity compared to its parent compound, it serves as a valuable tool for studying antibiotic metabolism and resistance mechanisms. This reagent is useful in research applications related to the assessment of beta-lactam antibiotics and their derivatives.

BMS-180680 is a broad-spectrum antibiotic targeting gram-negative bacteria. It demonstrates potent antibacterial activity against Pseudomonas aeruginosa with a minimum inhibitory concentration (MIC) of 0.25 µg/ml. Additionally, BMS-180680 is resistant to hydrolysis by various β-lactamases, including TEM-2 and PSE enzymes, making it a valuable tool for research in antibiotic resistance and drug development.

Pneumocandin A4 is a lipopeptide antibiotic that targets the synthesis of 1,3-β-glucan, crucial for fungal cell wall integrity. It exhibits significant antifungal activity against Candida species, demonstrating an IC50 range of 0.07-0.5 μg/mL in vitro. This compound is valuable for research applications focused on antifungal mechanisms and the development of new therapeutic agents against fungal infections.

Arisostatin B is a tetrocarcin class antibiotic primarily targeting Gram-positive bacteria. It exhibits significant antibacterial properties, making it effective in combatting infections caused by resistant strains. Additionally, Arisostatin B demonstrates antitumor activity, supporting its potential applications in cancer research and therapy development.

Anti-MRSA agent 12 is an antibiotic that demonstrates significant antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli, with minimum inhibitory concentrations (MIC) of 7.81 μM for both Staphylococcus species and 62.5 μM for E. coli. This compound specifically targets methicillin-resistant Staphylococcus aureus (MRSA) by effectively inhibiting biofilm formation. It is a valuable reagent for research in antibiotic resistance and biofilm-related infections.

Azidocillin sodium is a semi-synthetic β-lactam antibiotic that exhibits activity against bacterial infections. Characterized by its azide functionality, it retains antibacterial efficacy and can be employed in studies of osteitis associated with dental surgery, otitis media, and enterococcal septicemia. Additionally, Azidocillin sodium serves as a versatile click chemistry reagent, participating in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. This dual functionality enhances its utility in both microbiological research and chemical biology applications.

Ala0-Actagardine is a lantibiotic that targets bacterial cell membranes, derived from the cultures of Actinoplanes liguriae ATCC 31048. This compound exhibits potent antibacterial activity against a range of Gram-positive pathogens, making it valuable for research in antibiotic resistance and pathogen sensitivity studies. Its unique mechanism of action provides insights into peptide antibiotics and their potential therapeutic applications in infectious disease treatment.

Lankacidinol A is an antibiotic that demonstrates significant antibacterial activity against Gram-positive bacteria. This compound is utilized in research to investigate its efficacy in combating bacterial infections and may provide insights into novel antibiotic development. Its mechanism of action contributes to the growing understanding of antimicrobial resistance and the potential for new therapeutic strategies.

Nothramicin is an anthracycline antibiotic that primarily targets mycobacterial strains. It exhibits potent anti-mycobacterial activity, making it a valuable reagent for research focused on tuberculosis and other mycobacterial infections. This compound is essential for studies investigating the mechanisms of antibiotic resistance and the development of novel therapeutic strategies.

Arylomycin A3 is a lipohexapeptide antibiotic targeting Gram-positive bacteria. This compound exhibits potent antibacterial activity, making it valuable for research on antibiotic resistance and the development of new antimicrobial agents. Its mechanism involves inhibition of bacterial protein synthesis, offering insights into bacterial growth regulation and antibiotic pathways.

Lenapenem hydrochloride hydrate, a potent carbapenem antibiotic, exerts strong antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. This compound is utilized in research to elucidate mechanisms of bacterial resistance and to evaluate its therapeutic potential in treating severe bacterial infections. Its effectiveness against difficult-to-treat pathogens makes it a valuable tool in microbiological studies and antibiotic development.

Demycarosyl platenomycin primarily targets bacterial ribosomes as an antibiotic. It exhibits selective activity against Gram-positive bacteria, making it a useful tool for research in antibacterial mechanisms and the study of bacterial resistance. Its unique structure allows for exploration of antibiotic efficacy and resistance pathways, providing insights into the development of new therapeutic agents.

Epoxyquinomicin C is an antibiotic derived from the soil bacterium Amycolatopsis sp. It displays anti-inflammatory properties, particularly in models of collagen-induced arthritis, making it a valuable tool for studying inflammatory pathways. Additionally, Epoxyquinomicin C serves as a synthetic precursor for the NF-κB inhibitor DHMEQ, facilitating research into therapeutic applications targeting NF-κB signaling.

Pneumocandin B2 is a lipopeptide antibiotic that targets fungal cell wall synthesis by inhibiting 1,3-β-D-glucan. It demonstrates potent anti-Candida activity, with an inhibitory concentration (IC50) ranging from 0.07 to 0.5 μg/mL in vitro. This compound is primarily utilized in research focused on antifungal mechanisms and development of novel treatments for fungal infections.

13-Deoxycarminomycin is an antibiotic that primarily targets bacterial cells, exhibiting significant antibacterial activity. In addition to its antibiotic properties, this compound demonstrates cytotoxic effects against tumor cell lines such as HeLa and P388. It holds potential for applications in cancer research, particularly in exploring its anti-tumor mechanisms and therapeutic efficacy.

Cedarmycin B is an antibiotic that exhibits potent activity against fungal pathogens, specifically Candida species, Cryptococcus neoformans, and Aspergillus fumigatus. The minimum inhibitory concentration (MIC) values range from 12.5 to 50 μg/mL, indicating its effectiveness in inhibiting fungal growth. This compound is useful for research applications focused on antifungal drug development and resistance studies.

Aureonuclemycin is a nucleoside antibiotic derived from Staphylococcus aureus, featuring two distinct forms: Type A and Type B. Aureonuclemycin A shares structural similarities with certain herbicides and contains an adenine moiety, while Aureonuclemycin B comprises 5′-deoxyadenosine and demonstrates significant antibacterial activity. This compound is valuable in research focused on bacterial diseases, including bacterial leaf blight in rice, citrus canker, and bacterial leaf spot in rice, making it a crucial tool for studying plant-pathogen interactions and developing targeted antibacterial strategies.

Mycinamicin V is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits significant antibacterial activity against Gram-positive bacteria, making it a valuable compound for research in microbiology and infectious disease studies. Mycinamicin V is utilized in the investigation of bacterial resistance mechanisms and the development of new antimicrobial therapies.

LBM-415 is a peptide deformylase (PDF) inhibitor with demonstrated antibacterial activity against antimicrobial-resistant gram-positive cocci. It exhibits a minimum inhibitory concentration (MIC90) range of 0.12-8 µg/ml, indicating its potency in inhibiting bacterial growth. Additionally, the inhibition of efflux pump activity may enhance the sensitivity of bacteria to LBM-415, thereby improving its overall antibacterial efficacy. This compound serves as a valuable tool for research into antibiotic resistance and the development of novel therapeutic strategies.

Napyradiomycin A2 is an antibiotic that targets Gram-positive bacteria and exhibits significant mycobacterial activity. Its mechanism of action involves the interference with bacterial cell wall synthesis, making it a valuable tool in the study of antibiotic resistance and the development of novel therapeutic agents. This compound is suited for research applications in microbiology and drug discovery, particularly in the context of mycobacterial infections such as tuberculosis.

Sakyomicin B is a benzoquinone antibiotic that targets Gram-positive bacteria and mycobacteria. Isolated from the strain of Nocardia sp. M-53, it exhibits potent antimicrobial properties, making it valuable for research into bacterial infections and antibiotic resistance. Its unique mechanism and efficacy in combating specific bacterial strains highlight its significance in the field of microbiology and pharmacology.

Bicyclomycin is an antibiotic that targets bacterial RNA polymerase, inhibiting bacterial transcription. It exhibits selective antibacterial activity against Gram-negative bacteria, including Escherichia coli and Klebsiella species, without cross-resistance. Bicyclomycin is valuable for research focusing on infectious diseases and the mechanisms of antibiotic resistance.

Arugomycin is an anthracycline antibiotic primarily targeting Gram-positive bacteria. Its mechanism of action involves intercalation into DNA, which also suggests potential as an antitumor agent. This compound is valuable for research in antibiotic resistance and cancer therapeutics.

Fluvirucin B3 is an antibiotic that targets the influenza A virus. It has demonstrated significant antiviral activity, making it a valuable compound for research focused on influenza infections. Its application in laboratory studies provides insights into the mechanisms of viral resistance and aids in the development of novel therapeutic strategies against influenza A virus.

Epoxyquinomicin D is a potent antibiotic derived from Amycolatopsis sp., primarily targeting bacterial pathogens. It demonstrates notable anti-inflammatory properties, particularly in models of collagen-induced arthritis. This compound is valuable in research focused on antibiotic efficacy and the modulation of inflammatory processes in autoimmune conditions.

1,5-Dideoxy-1,5-imino-D-mannitol is an antibiotic that exhibits antibacterial properties through its action on bacterial cell wall synthesis. This compound is valuable for research aimed at understanding bacterial resistance mechanisms and the development of new antibacterial agents. Its specific activity against various bacterial strains makes it an important tool in antimicrobial studies.

Cefoxazole is a β-lactam antibiotic that contains an isoxazole moiety, primarily targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against a range of Gram-positive and Gram-negative organisms. Cefoxazole is applicable in research related to the treatment and study of infectious diseases, particularly in evaluating its efficacy against resistant strains.

Emerin is an antibiotic derived from the fungal strain Aspergillus nidulans. It exhibits potent antibacterial activity, primarily targeting bacterial ribosomes to inhibit protein synthesis. Emerin has valuable applications in microbiological research and the study of bacterial resistance mechanisms.